Armistice Capital, LLC Bio Rad Laboratories, Inc. Transaction History

Armistice Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $11.8 Million - $14.9 Million	-18,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $11.5 Million - $13 Million	-20,000 Reduced 52.63%	18,000 $11.6 Million
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $2.74 Million - $3.31 Million	5,000 Added 15.15%	38,000 $21.7 Million
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $6.64 Million - $8.36 Million	13,000 Added 65.0%	33,000 $19.2 Million
Q3 2020 Nov 16, 2020	BUY	$454.43 - $535.6 $9.09 Million - $10.7 Million	20,000 New	20,000 $10.3 Million
Q1 2020 May 15, 2020	SELL	$320.01 - $409.07 $6.4 Million - $8.18 Million	-20,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$319.73 - $374.2 $6.39 Million - $7.48 Million	20,000 New	20,000 $7.4 Million

453

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.68B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.